Wiseguyreports.Com Adds “Biochips -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database
Global Biochips Market is predicted to grow at the CAGR of 18% during 2016-2021. A biochip is a miniaturized laboratories or microarrays that performs thousands of simultaneous biochemical reactions. Biochips are used to perform multiple tests and enable to achieve higher output and speed. Biochips Market is driven by significant demand in personalized medicine and drug discovery & development due to faster test results and accuracy. Growth & demand of Diagnostic market is boosting the global biochips market. Technological advancement and adoption of automation techniques are creating huge scope for biochips market due to faster results and enhanced efficiency of biochips products. Biochips contain very micro sensors which enable to perform speedier test in short period of time.
Research & Development in human genome project enables to explore DNA sequencing through biochips. Biochips technology is boosted by the growth and advancement of proteomics & genomics market. DNA chips are widely adopted for gene expression, gene mapping and genotyping. Biochips have wide application which includes genomics, drug discovery & development, proteomics & genomics. In Vitro Diagnostics (IVD) & Point of Care Diagnostics (POC) are growing at a significant rate due to huge demand from developed and emerging economies. Rising life style oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases are boosting the biochips market.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/1509680-global-biochips-market-research-and-analysis-2015-2021
Global Biochips Market by application has wide variety among DNA chips market, Lab on a Chip Market and Protein Chips Market which are boosting the global Biochips Market. Technological advancement and R&D are the key strategies adopted by the Biochips companies to stay competitive. Baby Biochips is in nascent stage and expected to boost the chances of conception in infertile couples in near future. The report covers the patent analysis and research & development scenario of global Biochips market.
North America has the highest contribution to Global Biochips Market followed by Europe due to significant adoption of Biochips in hospitals, research centers and academic institutes. North America is contributing nearly half of the total market share due to huge adoption of Biochips applications and huge investment in Biochips market. Untapped APAC region such as China, India, Japan and Korea are expected to create huge opportunity for global Biochips market due to huge demand of Biochips application for diagnostics. APAC region is predicted to be a lucrative region due to rising life style oriented diseases, increase in adoption of biochips in research institutes and hospitals and improved healthcare spending.
The Key players of Global Biochips Market includes: Abbott Laboratories, Affymetrix Inc., Agilent Technologies, Inc., Biofluidix GMBH, Bio-Rad Laboratories Inc., Cellix, Cepheid Inc., Compugen, Epigem Ltd, Fluidigm Corporation, GE Healthcare, Helicos Bioscences, Illumina, Inc., Lifesensors, Medtronic, Micropoint Bioscience, Inc, Perkinelmer, Inc., Roche Diagnostics, Silicon Biosystems, Thermo Fisher Scientific, Inc. R&D, Partnership, product launch and Collaboration are the key winning strategies adopted by Global Biochips Market players across the globe.
Global Biochips Market is segmented on the basis of type, fabrication, end user and region. Global Biochips Market by type includes DNA chips market, Lab on a Chips, Protein Chips and other arrays Market. Global Biochips Market by Fabrication technology includes Microarrays, Microfluidics market. Global Biochips Market by end user includes Hospitals, Diagnostic centers, Research Institutes, Academic Institutes and other end user.
Table of Content
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
MARKET OVERVIEW AND INSIGHTS
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PATENT ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
7.1. ABBOTT LABORATORIES
7.1.2. ABBOTT LABORATORIES PRODUCT PORTFOLIO
7.1.3. ABBOTT LABORATORIES RECENT ACTIVITIES
7.1.4. ABBOTT LABORATORIES SWOT ANALYSIS
7.2. AFFYMETRIX INC.
7.2.2. AFFYMETRIX INC. PRODUCT PORTFOLIO
7.2.3. AFFYMETRIX INC. RECENT ACTIVITIES
7.2.4. AFFYMETRIX INC. SWOT ANALYSIS
7.3. AGILENT TECHNOLOGIES, INC.
7.3.2. AGILENT TECHNOLOGIES, INC. PRODUCT PORTFOLIO
7.3.3. AGILENT TECHNOLOGIES, INC. RECENT ACTIVITIES
7.3.4. AGILENT TECHNOLOGIES, INC. SWOT ANALYSIS
7.4. BIOFLUIDIX GMBH
7.4.2. BIOFLUIDIX GMBH PRODUCT PORTFOLIO
7.4.3. BIOFLUIDIX GMBH RECENT ACTIVITIES
7.4.4. BIOFLUIDIX GMBH SWOT ANALYSIS
7.5. BIO-RAD LABORATORIES INC.
7.5.2. BIO-RAD LABORATORIES INC. PRODUCT PORTFOLIO
7.5.3. BIO-RAD LABORATORIES INC. RECENT ACTIVITIES
7.5.4. BIO-RAD LABORATORIES INC. SWOT ANALYSIS
7.6.2. CELLIX PRODUCT PORTFOLIO
7.6.3. CELLIX RECENT ACTIVITIES
7.6.4. CELLIX SWOT ANALYSIS
7.7. CEPHEID INC.
7.7.2. CEPHEID INC. PRODUCT PORTFOLIO
7.7.3. CEPHEID INC. RECENT ACTIVITIES
7.7.4. CEPHEID INC. SWOT ANALYSIS
7.8.2. COMPUGEN PRODUCT PORTFOLIO
7.8.3. COMPUGEN RECENT ACTIVITIES
7.8.4. COMPUGEN SWOT ANALYSIS
7.9. EPIGEM LTD
7.9.2. EPIGEM LTD PRODUCT PORTFOLIO
7.9.3. EPIGEM LTD RECENT ACTIVITIES
7.9.4. EPIGEM LTD SWOT ANALYSIS
7.10. FLUIDIGM CORPORATION
7.10.2. FLUIDIGM CORPORATION PRODUCT PORTFOLIO
7.10.3. FLUIDIGM CORPORATION RECENT ACTIVITIES
7.10.4. FLUIDIGM CORPORATION SWOT ANALYSIS
7.11. GE HEALTHCARE
7.11.2. GE HEALTHCARE PRODUCT PORTFOLIO
7.11.3. GE HEALTHCARE RECENT ACTIVITIES
7.11.4. GE HEALTHCARE SWOT ANALYSIS
7.12. HELICOS BIOSCENCES
7.12.2. HELICOS BIOSCENCES PRODUCT PORTFOLIO
7.12.3. HELICOS BIOSCENCES RECENT ACTIVITIES
7.12.4. HELICOS BIOSCENCES SWOT ANALYSIS
7.13. ILLUMINA, INC.
7.13.2. ILLUMINA, INC. PRODUCT PORTFOLIO
7.13.3. ILLUMINA, INC. RECENT ACTIVITIES
7.13.4. ILLUMINA, INC. SWOT ANALYSIS
7.14.2. LIFESENSORS PRODUCT PORTFOLIO
7.14.3. LIFESENSORS RECENT ACTIVITIES
7.14.4. LIFESENSORS SWOT ANALYSIS
7.15.2. MEDTRONIC PRODUCT PORTFOLIO
7.15.3. MEDTRONIC RECENT ACTIVITIES
7.15.4. MEDTRONIC SWOT ANALYSIS
7.16. MICROPOINT BIOSCIENCE, INC
7.16.2. MICROPOINT BIOSCIENCE, INC PRODUCT PORTFOLIO
7.16.3. MICROPOINT BIOSCIENCE, INC RECENT ACTIVITIES
7.16.4. MICROPOINT BIOSCIENCE, INC SWOT ANALYSIS
7.17. PERKINELMER, INC.
7.17.2. PERKINELMER, INC. PRODUCT PORTFOLIO
7.17.3. PERKINELMER, INC. RECENT ACTIVITIES
7.17.4. PERKINELMER, INC. SWOT ANALYSIS
7.18. ROCHE DIAGNOSTICS
7.18.2. ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
7.18.3. ROCHE DIAGNOSTICS RECENT ACTIVITIES
7.18.4. ROCHE DIAGNOSTICS SWOT ANALYSIS
7.19. SILICON BIOSYSTEMS
7.19.2. SILICON BIOSYSTEMS PRODUCT PORTFOLIO
7.19.3. SILICON BIOSYSTEMS RECENT ACTIVITIES
7.19.4. SILICON BIOSYSTEMS SWOT ANALYSIS
7.20. THERMO FISHER SCIENTIFIC, INC.
7.20.2. THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
7.20.3. THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Phone: +1 646 845 9349, +44 208 133 9349